Cargando…

P1593: DECIPHERING UNIQUE HETEROGENEITY AND EFFICACY DIFFERENCES IN IMMUNE THROMBOCYTOPENIA AT THE SINGLE-CELL LEVEL

Detalles Bibliográficos
Autores principales:	Xu, Min, Tang, Lu, Hu, Yu, Mei, Heng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430304/ http://dx.doi.org/10.1097/01.HS9.0000973248.98614.30

Ejemplares similares

P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
por: Tamariz-Amador, L.-E., et al.
Publicado: (2022)

1593 Predictors of Mortality for HIV-associated Cryptococcal Meningitis
por: Nimitvilai, Sireethorn, et al.
Publicado: (2014)

P845: DECIPHERING PLASMA CELL HETEROGENEITY AND TRANSCRIPTOME FEATURES IN POEMS SYNDROME USING SINGLE CELL RNA-SEQUENCING
por: He, Haiyan, et al.
Publicado: (2023)

P1643: EFFICACY OF RECOMBINANT HUMANTHROMBOPOIETIN ON CHILDREN IMMUNE THROMBOCYTOPENIA AND ITS INFLUENCING FACTORS
por: Ma, J., et al.
Publicado: (2022)

P874: DECIPHERING PLASMA CELL HETEROGENEITY AND TUMOR MICROENVIRONMENT IN LIGHT-CHAIN AMYLOIDOSIS USING SINGLE CELL RNA-SEQUENCING
por: Srivastava, A., et al.
Publicado: (2022)

P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIAL
por: Mei, Heng, et al.
Publicado: (2023)

Vida del soldado español Miguel Castro, 1593-1611 : escrita por el mismo.
por: Castro, Miguel de, b.1593-
Publicado: (1949)

P1615: ASPECTS OF THE THERAPY SELECTION FOR IMMUNE THROMBOCYTOPENIA IN CHILDREN
por: Khoduleva, Sviatlana, et al.
Publicado: (2023)

1593. Analysis of Hospital Antimicrobial Susceptibility Test Results for Patterns of Antibiotic Resistance
por: Beckley, Andrew, et al.
Publicado: (2019)

1593P COVID-19 vaccine acceptance among Tunisian cancer patients: A cross-sectional study
por: Ouertani, E., et al.
Publicado: (2021)

Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia
por: Liu, Yan, et al.
Publicado: (2022)

P1629: DISCONTINUATION OF TREATMENT WITH THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE-CENTER CLINICAL EXPERIENCE
por: Santano, Ana María Mena, et al.
Publicado: (2023)

P1653: CLINICAL EFFICACY AND SAFETY OF SWITCHING ELTROMBOPAG AND RH-TPO IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA DURING THE COVID-19 PANDEMIC
por: Cai, X., et al.
Publicado: (2022)

P1669: AUTOANTIBODY-MEDIATED PLATELET DESIALYLATION IN ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA
por: Schramm, T., et al.
Publicado: (2022)

P1594: BARICITINIB FOR STEROID-RESISTANT/RELAPSE IMMUNE THROMBOCYTOPENIA (BAITP): AN OPEN-LABEL, SINGLE-ARM, PHASE 2 TRIAL
por: Zhao, Peng, et al.
Publicado: (2023)

1593. Antimicrobial Activity of Ceftazidime-Avibactam and Comparator Agents Against OXA-48 β-lactamase–Producing Enterobacterales Collected in International Medical Centers, Including the United States, in 2017–2018
por: Lin, Lynn-Yao, et al.
Publicado: (2020)

P1666: EFFECT OF AGONISTS TO THROMBOPOIETIN RECEPTORS ON PLATELET GLYCOME OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA
por: Monzón Manzano, E., et al.
Publicado: (2022)

‘Carriers of V‐LH among 1593 Baltic men have significantly higher serum LH’
por: Punab, A. M., et al.
Publicado: (2015)

1593. Switch to DOVATO in Patients Suppressed on Biktarvy (The SOUND Study), week 48 interim analysis
por: Slim, Jihad, et al.
Publicado: (2023)

P1604: IMPACT OF THROMBOPOIETIN LEVEL ON PLATELET RESPONSE IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA TREATED WITH RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR
por: Kuter, David, et al.
Publicado: (2023)

P1625: CLINICAL AND LABORATORY CHARACTERISTICS OF ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN EASTERN AUSTRIA
por: Rast, Jasmin, et al.
Publicado: (2023)

P1044: REAL-WORLD RUXOLITINIB TREATMENT PATTERN IN MYELOFIBROSIS PATIENTS WITH THROMBOCYTOPENIA
por: Mei, J., et al.
Publicado: (2022)

P1651: HDAC3 RS2530223 IS ASSOCIATED WITH INCREASED SUSCEPTIBILITY AND SEVERITY OF PRIMARY IMMUNE THROMBOCYTOPENIA
por: Wang, S.
Publicado: (2022)

P1595: ACTIVATION OF CHAPERONE-MEDIATED AUTOPHAGY REDUCES NLRP3 AND PLATELET CLEARANCE IN IMMUNE THROMBOCYTOPENIA
por: Xu, Yitong, et al.
Publicado: (2023)

P1601: PREDICTING THE RESPONSE TO SPLENECTOMY IN IMMUNE THROMBOCYTOPENIA (ITP): A MULTI-CENTRIC PILOT STUDY
por: Zoletto, Simone, et al.
Publicado: (2023)

Different but Not Unique: Deciphering the Immunity of the Jamaican Fruit Bat by Studying Its Viriome
por: David, Quinnlan, et al.
Publicado: (2022)

P1635: REAL-WORLD DATA OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) USE IN IMMUNE THROMBOCYTOPENIA (ITP)
por: Dangudubiyyam, S., et al.
Publicado: (2022)

P1596: EFFICACY AND SAFETY OF QL0911 IN ADULT PATIENTS WITH CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL
por: Zhou, Hu, et al.
Publicado: (2023)

P1654: COMPLEMENT ACTIVATION REGULATES PLATELET HOMEOSTASIS BY ARRESTING THE ANTI-INFLAMMATORY EFFECTS OF INTERLEUKIN-35 IN IMMUNE THROMBOCYTOPENIA
por: Gui, R.-Y., et al.
Publicado: (2022)

P1655: PERSONALIZED MACHINE-LEARNING-BASED PREDICTION FOR CRITICAL IMMUNE THROMBOCYTOPENIA BLEEDS: A NATIONWIDE DATA STUDY
por: An, Z.-Y., et al.
Publicado: (2022)

P1636: PATIENT PREFERENCES AND EXPERIENCES REGARDING THROMBOPOIETIN-RECEPTOR AGONISTS FOR IMMUNE THROMBOCYTOPENIA IN THE NETHERLANDS (TRAPEZE NL STUDY).
por: Jansen, A. G., et al.
Publicado: (2022)

P1591: IMPACT OF COVID-19 ON THE EVOLUTION OF PRE-EXISTING PRIMARY IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE OBSERVATIONAL STUDY
por: Fu, Haixia, et al.
Publicado: (2023)

P322: DECIPHERING THE UNDERLYING MOLECULAR COMPLEXITY OF THE IKZF1PLUS SIGNATURE
por: Lühmann, Jonathan, et al.
Publicado: (2023)

Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP
por: Georgi, Julia-Annabell, et al.
Publicado: (2023)

P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Eshaghpour, Ali, et al.
Publicado: (2023)

P1294: SINGLE-CELL RNA SEQUENCING REVEALS TUMOR CELL HETEROGENEITY AND COMPREHENSIVE IMMUNE PROFILE OF T FOLLICULAR HELPER CELL LYMPHOMA
por: Suma, S., et al.
Publicado: (2022)

Dissertatio medica inauguralis... Leyden medical dissertations in the British Library 1593–1746: catalogue of a Sloane-inspired collection
por: Luyendijk-Elshout, A M
Publicado: (1999)

P1634: EFFICACY AND SAFETY OF ELTROMBOPAG IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION PATIENTS WITH THROMBOCYTOPENIA（HBV-TP）: A PROSPECTIVE, MULTI-CENTER, SINGLE ARM, PHASE II TRAIL
por: Chen, Y., et al.
Publicado: (2022)

P1659: UNIQUE GENOTYPE-PHENOTYPE RELATIONSHIP IN VON WILLEBRAND DISEASE: A SINGLE CENTRE EXPERIENCE
por: Elshinawy, M.
Publicado: (2022)

P1647: CONTRIBUTION OF NEXT GENERATION FLOW (NGF) CYTOMETRY IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP): UTILITY FOR THE DIFFERENTIAL DIAGNOSIS WITH MYELODYSPLASTIC SYNDROMES
por: Gonzalez-Lopez, T. J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oavtjnnvk5vu68p3fn8jhummqq